Safety Evaluation of Standardized Extract of Curcuma longa (NR-INF-02): A 90-Day Subchronic Oral Toxicity Study in Rats

Abstract

NR-INF-02 is a standardized extract containing turmerosaccharides from Curcuma longa that has anti-inflammatory, analgesic, and chondroprotective potential. In view of its potential uses, NR-INF-02 was evaluated for its safety in Wistar rats at an oral dose of 250, 500, and 1000 mg/kg in a 90-day repeated dose subchronic toxicity study. NR-INF-02 administered at 250, 500, and 1000 mg/kg for 90 days did not show any mortality or clinical signs of toxicity. Body weight gain, food consumption, ocular and neurological examination, and hematological, blood biochemical, hormone, and urine analysis revealed no evidence of toxicity of NR-INF-02 treatment in rats. Absolute and relative organ weights were comparable to control rats. The study did not reveal any major treatment related gross pathological and histopathological alterations in the tissues or organs examined. Thus, based on study observations, the no-observed adverse effect level (NOAEL) was found to be 1000 mg/kg body weight in albino Wistar rats.

Preclinical evaluation of a gel composition based on a flavonoid complex for the treatment of periodontal diseases in orthodontic patients

“…The presence of a toxic-cumulative effect upon GCB oral administration into rat bodies (n = 10) -the severity degree of the toxic "accumulation" effect in a living organism (cumulation coefficient -K cum. ) -was determined by the method of "subchronic toxicity" [17,18]. GCB was administered in its native form, starting with a dose of 600 mg/kg with a dose increase of 1.5 times every 4 days.…”

Mechanistic pathway of herbs in the amelioration of NAFLD: A systematic review

“…The extracts of Antidesma bunius (82,83), Aralia elata (84)(85)(86), Citrus aurantium (90)(91)(92)(93), Curcuma longa Linn. (94)(95)(96), Cyclosorus terminans (101,102), Panax notoginseng (109), Pluchea indica (114), and Rosmarinus of f icinalis Linn (115,116) have also been shown to reduce the accumulation of lipids in rats fed a HFD through sterol regulatory element-binding transcription factor 1c (SREBP-1c), peroxisome proliferator-activated receptor-α (PPAR-α), fatty acid synthase (FAS), acetyl-CoA carboxylase (ACC), and carnitine palmitoyltransferase (CPT)2 regulation. The adenosine monophosphate-activated protein kinase (AMPK) pathway plays a crucial role in regulating hepatic lipogenesis and β-oxidation and serves as a vital energy sensor for intracellular energy metabolism.…”

“…The ethanol extract of 200 mg/kg Rubus ideaus has been shown to significantly decrease the level of malondialdehyde, while increasing the levels of the antioxidants, superoxide dismutase, glutathione and glutathione peroxidase, thereby reducing liver oxidative stress (117). The extracts of Aralia elata (84)(85)(86), Curcuma longa (94)(95)(96), Cyclosorus terminans (100-102), Panax notoginseng (109), and Pluchea indica (114) have been found to significantly promote fatty acid oxidation through the activation of PPAR-α and PPAR-γ.…”

An update on molecular mechanisms of curcumin effect on diabetes

“…The safety and tolerability of curcumin in high concentration (1000 mg/kg in both male and female animals) have been confirmed by various animal models (Murugan et al, 2021). However, it is not recommended to prescribe curcumin supplementation in pregnant or lactating women, children, or individuals with anemia or liver illness due to the lack of sufficient evidence of curcumin safety for these populations.…”